Kamada Ltd. reported $180M of revenue over the trailing twelve months, +12% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $180M (to Q4 2025). Net income: $20M, trailing twelve months to Q3 2025. Operating margin: 15%, trailing twelve months to Q4 2025. EPS: $0.35, trailing twelve months to Q4 2025.

KMDAKamada Ltd.

Healthcare

$7.78+21% 1Y

$7.78

$6.4152 weeks$9.04

KMDA as reported

Kamada Ltd. reported $180M of revenue over the trailing twelve months, +12% on the year before. 10 reported series are charted on this page, each one as filed.

$180M

Revenue, trailing twelve months · to Q4 2025 · +12% against the twelve months before

Net income: $20M
Net income · trailing twelve months to Q3 2025
Operating margin: 15%
Operating margin · trailing twelve months to Q4 2025
EPS: $0.35
EPS · +35% year on year · trailing twelve months to Q4 2025

Details›

Every series Ryufin has for KMDA, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$180M	+12%	Q4 2025
Net income	$20M	n/a	Q3 2025
EPS	$0.35	+35%	Q4 2025
Gross margin	42%	n/a	Q4 2025
Operating margin	15%	n/a	Q4 2025
Net margin	12%	n/a	Q3 2025
ROE	6.7%	n/a	Q3 2025
ROA	4.7%	n/a	Q3 2025
ROIC	11%	n/a	Q4 2025
P/E	22.2	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.